stella
beta
A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma — Stella
Home
/
Multiple Myeloma in Relapse
/
A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
View on ClinicalTrials.gov
Recruiting
Back to Multiple Myeloma in Relapse trials
A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
United States
Berenson Cancer Center, West Hollywood, California
Nebraska Cancer Specialists, Omaha, Nebraska